4 studies found for:    "Rhabdomyosarcoma alveolar"
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
Conditions: Neuroblastoma;   Sarcoma;   Rhabdomyosarcoma-Embryonal;   Rhabdomyosarcoma- Alveolar;   Neuroectodermal Tumors, Primitive, Peripheral
Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes;   Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine;   Drug: rhIL-7;   Biological: Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
2 Recruiting CREATE: Cross-tumoral Phase 2 With Crizotinib
Conditions: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma;   Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor;   Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1;   Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma;   Locally Advanced and/or Metastatic Clear Cell Sarcoma;   Locally Advanced and/or Metastatic Alveolar Rhabdomyosarcoma
Intervention: Drug: Crizotinib (PF-02341066)
3 Recruiting Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
Conditions: Alveolar Childhood Rhabdomyosarcoma;   Embryonal Childhood Rhabdomyosarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Previously Untreated Childhood Rhabdomyosarcoma;   Recurrent Childhood Rhabdomyosarcoma
Intervention: Other: laboratory biomarker analysis
4 Unknown  Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Conditions: Carcinoid;   Neuroendocrine
Intervention: Drug: Seneca Valley Virus (biological agent)

Indicates status has not been verified in more than two years